Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Li, Jia-Yi, Englund, Elisabet, Holton, Janice L, Soulet, Denis, Hagell, Peter, Lees, Andrew J, Lashley, Tammaryn, Quinn, Niall P +6 more·2008·Nature Medicine

DOI 10.1038/nm1746

Cited by (1,002)

Items 201–300 of 1,002

Prion-like aggregation of mutant p53 in cancer
Jerson Lima Silva, C. V. de Moura Gallo, Danielly C. Ferraz da Costa, Luciana Pereira Rangel · 2014 · Trends in Biochemical Sciences
RETRACTED ARTICLE: Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology
Ngolab, Jennifer, Trinh, Ivy, Rockenstein, Edward, Mante, Michael, Florio, Jazmin, Trejo, Margarita, Masliah, Deborah, Adame, Anthony, Masliah, Eliezer, Rissman, Robert A. · 2017 · Acta Neuropathologica Communications · Retracted
Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology
Manfredsson, Fredric P., Luk, Kelvin C., Benskey, Matthew J., Gezer, Aysegul, Garcia, Joanna, Kuhn, Nathan C., Sandoval, Ivette M., Patterson, Joseph R., O'Mara, Alana, Yonkers, Reid et al. · 2018 · Neurobiology of Disease
Molecular and clinical prodrome of Parkinson disease: implications for treatment
Anthony H.V. Schapira, EDUARDO S. TOLOSA · 2010 · Nature Reviews Neurology
Autophagic failure promotes the exocytosis and intercellular transfer of α-synuclein
He-Jin Lee, Eun-Duk Cho, Kyungwon Lee, Jung‐Hyun Kim, Ssang‐Goo Cho, Seung‐Jae Lee · 2013 · Experimental & Molecular Medicine
Tau Pathology in Parkinson's Disease
Xue Zhang, Fei Gao, Dongdong Wang, Chao Li, Yi Fu, Wei He, Jianmin Zhang · 2018 · Frontiers in Neurology
Reverse engineering Lewy bodies: how far have we come and how far can we go?
Mohamed Bilal Fares, Somanath Jagannath, Hilal Ahmed Lashuel · 2021 · Nature reviews. Neuroscience
Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration
Francesca Cicchetti, Samuel Saporta, Robert A. Hauser, Martin Parent, Martine Saint‐Pierre, Paul R. Sanberg, Xinxun Li, John R. Parker, Yaping Chu, Elliott Jay Mufson et al. · 2009 · Proceedings of the National Academy of Sciences
Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
Minjeong Park, Sang‐Myung Cheon, Hye-Ran Bae, Sang-Ho Kim, Jae Woo Kim · 2011 · Journal of Clinical Neurology
Milestones in Parkinson's disease therapeutics
Olivier Rascol, Andrés M. Lozano, Matthew Stern, Werner H Poewe · 2011 · Movement Disorders
The Threshold Theory for Parkinson's Disease
Simone Engelender, Ole Isacson A · 2016 · Trends in Neurosciences
Mutant huntingtin is present in neuronal grafts in huntington disease patients
Cicchetti, Francesca, Lacroix, Steve, Cisbani, Giulia, Vallières, Nicolas, Saint‐Pierre, Martine, St‐Amour, Isabelle, Tolouei, Ranna, Skepper, Jeremy N., Hauser, Robert A., Mantovani, Diego et al. · 2014 · Annals of Neurology
Human-to-mouse prion-like propagation of mutant huntingtin protein
Iksoo Jeon, Francesca Cicchetti, Giulia Cisbani, Suji Lee, Endan Li, Jiwoo Bae, Nayeon Lee, Ling Li, Wooseok Im, Manho Kim et al. · 2016 · Acta Neuropathologica
Gut–brain axis and the spread of α‐synuclein pathology: Vagal highway or dead end?
Breen, David P., Halliday, Glenda M., Lang, Anthony E. · 2019 · Movement Disorders
Tunnelling nanotubes between neuronal and microglial cells allow bi-directional transfer of α-Synuclein and mitochondria
Chakraborty, Ranabir, Nonaka, Takashi, Hasegawa, Masato, Zurzolo, Chiara · 2023 · Cell Death & Disease
Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies
Mathieu Bourdenx, Nikolaos Stavros Koulakiotis, Despina Sanoudou, Erwan Bézard, Benjamin Dehay, Anthony Tsarbopoulos · 2015 · Progress in Neurobiology
Formation and development of Lewy pathology: a critical update
K. A. Jellinger · 2009 · Journal of Neurology
Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease.
O. Lindvall, Z. Kokaia · 2009 · TIPS - Trends in Pharmacological Sciences
Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles
Luis Daniel Bernal-Conde, Rodrigo Ramos-Acevedo, Mario A. Reyes-Hernández, Andrea Joselin Balbuena-Olvera, Ishbelt D. Morales-Moreno, Rubén Argüero‐Sánchez, Birgitt Schüle, Magdalena Guerra‐Crespo · 2020 · Frontiers in Neuroscience
Parkinson's Disease Is Not Simply a Prion Disorder
Dalton James Surmeier, Jose Angel Obeso, Glenda Margaret Halliday · 2017 · Journal of Neuroscience
Impaired intracellular trafficking defines early Parkinson's disease
Benjamin H.M. Hunn, Stephanie Jane Cragg, J. Paul Bolam, MariaGrazia Spillantini, Richard Wade‐Martins · 2015 · Trends in Neurosciences
Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and <sup>18</sup>F-FDOPA PET Outcomes
Ma, Yilong, Tang, Chengke, Chaly, Thomas, Greene, Paul, Breeze, Robert, Fahn, Stanley, Freed, Curt, Dhawan, Vijay, Eidelberg, David · 2010 · Journal of Nuclear Medicine
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Carmen I. Nussbaum-Krammer, Mário F. Neto, Renée M. Brielmann, Jesper Søndergaard Pedersen, Richard I. Morimoto · 2015 · Journal of Visualized Experiments
Prion-like spread of protein aggregates in neurodegeneration
Polymenidou, Magdalini, Cleveland, Don W. · 2012 · Journal of Experimental Medicine
The concept of alpha-synuclein as a prion-like protein: ten years after
Steiner, Jennifer A., Quansah, Emmanuel, Brundin, Patrik · 2018 · Cell and Tissue Research
Seeded assembly <i>in vitro</i> does not replicate the structures of α‐synuclein filaments from multiple system atrophy
Lövestam, Sofia, Schweighauser, Manuel, Matsubara, Tomoyasu, Murayama, Shigeo, Tomita, Taisuke, Ando, Takashi, Hasegawa, Kazuko, Yoshida, Mari, Tarutani, Airi, Hasegawa, Masato et al. · 2021 · FEBS Open Bio
Parkinson disease and the gut: new insights into pathogenesis and clinical relevance
Travagli, R. Alberto, Browning, Kirsteen N., Camilleri, Michael · 2020 · Nature Reviews Gastroenterology & Hepatology
Protein aggregate spreading in neurodegenerative diseases: Problems and perspectives
Seung‐Jae Lee, Hee-Sun Lim, Eliezer Masliah, He-Jin Lee · 2011 · Neuroscience Research
Beyond the prion principle
Adriano Aguzzi · 2009 · Nature
Alpha-synuclein spreading in Parkinson’s disease
Ariadna Recasens, Benjamin Dehay · 2014 · Frontiers in Neuroanatomy
Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
Viviane S. Tabar, Harini Sarva, Andrés M. Lozano, Alfonso A. Fasano, Suneil Kumar Kalia, Kenny Kwok Hei Yu, Cameron Walter Brennan, Yilong Ma, Shichun Peng, David Eidelberg et al. · 2025 · Nature
Rotenone-Induced Model of Parkinson’s Disease: Beyond Mitochondrial Complex I Inhibition
María Teresa Ibarra-Gutiérrez, Norma Serrano‐García, Marisol Orozco‐Ibarra · 2023 · Molecular Neurobiology
Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications
Qian Huang, Maria E. Figueiredo‐Pereira · 2010 · APOPTOSIS
Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation
Marcel Kunadt, Katrin Eckermann, Anne Stuendl, Jing Gong, Belisa Russo, Katrin Strauss, Surya Rai, Sebastian Kügler, Lisandro J. Falomir‐Lockhart, M. Schwalbe et al. · 2015 · Acta Neuropathologica
Intercellular (Mis)communication in Neurodegenerative Disease
Gwenn A. Garden, Albert R. La Spada · 2012 · Neuron
Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat
Jeffrey H. Kordower, Hemraj B. Dodiya, Adam M. Kordower, Brian T. Terpstra, Katrina L. Paumier, Lalitha Madhavan, Caryl E. Sortwell, Kathy Steece‐Collier, Timothy J. Collier · 2011 · Neurobiology of Disease
Synaptic failure and α‐synuclein
Laura Calò, Michał Węgrzynowicz, Jessica Santivañez‐Perez, Maria Grazia Spillantini · 2016 · Movement Disorders
Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synuclein
Dilshan S. Harischandra, Dharmin Rokad, Matthew P Neal, Shivani Ghaisas, Sireesha Manne, Souvarish Sarkar, Nikhil Panicker, Gary D. Zenitsky, Huajun Jin, Mechelle M. Lewis et al. · 2019 · Science Signaling
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Luís M. A. Oliveira, Thomas Gasser, Robert H. Edwards, Markus Zweckstetter, Ronald Melki, Leonidas Stefanis, Hilal Ahmed Lashuel, David L. Sulzer, Kostas Vekrellis, Glenda Margaret Halliday et al. · 2021 · npj Parkinson s Disease
Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease
Eleonora Carboni, Paul Lingor · 2015 · Metallomics
Evaluation of Potential Infectivity of Alzheimer and Parkinson Disease Proteins in Recipients of Cadaver-Derived Human Growth Hormone
David John Irwin, Joseph Y. Abrams, Lawrence B. Schonberger, Ellen Leschek, James L. Mills, Virginia M.‐Y. Lee, John Q. Trojanowski · 2013 · JAMA Neurology
Biological links between traumatic brain injury and Parkinson’s disease
Delic, Vedad, Beck, Kevin D., Pang, Kevin C. H., Citron, Bruce A. · 2020 · Acta Neuropathologica Communications
Gene–environment interactions: Key to unraveling the mystery of Parkinson's disease
Hui‐Ming Gao, Jau‐Shyong Hong · 2011 · Progress in Neurobiology
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
Chao Peng, Ronald J. Gathagan, Virginia M.‐Y. Lee · 2017 · Neurobiology of Disease
The cell biology of Parkinson’s disease
Nikhil Panicker, Preston Ge, Valina Lynn Dawson, Ted M. Dawson · 2021 · The Journal of Cell Biology
Assessment of α-Synuclein Secretion in Mouse and Human Brain Parenchyma
Emmanouilidou, Evangelia, Elenis, Dimitris, Papasilekas, Themis, Stranjalis, Georgios, Gerozissis, Kyriaki, Ioannou, Penelopi C., Vekrellis, Kostas · 2011 · PLoS ONE
Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein
María Eugenia Bernis, Julius T. Babila, Sara Breid, Katharina Annick Wüsten, Ullrich Wüllner, Gültekin Tamgüney · 2015 · Acta Neuropathologica Communications
Axonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1
Michel Brahic, Luc Bousset, Gregor Bieri, Ronald Melki, Aaron D. Gitler · 2016 · Acta Neuropathologica
Neural Stem Cells: Historical Perspective and Future Prospects
Joshua J. Breunig, Tarik F. Haydar, PASKO T. RAKIC · 2011 · Neuron
Extracellular Interactions of Alpha-Synuclein in Multiple System Atrophy
Dario Valdinocci, Rowan A. W. Radford, Michael Goulding, Junna Hayashi, Roger S. Chung, Dean L. Pountney · 2018 · International Journal of Molecular Sciences
Multiple system atrophy: a clinical and neuropathological perspective
Kiren K. Ubhi, Phillip A. Low, Eliezer Masliah · 2011 · Trends in Neurosciences
α-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson’s disease patients
Dieriks, Birger Victor, Park, Thomas I-H., Fourie, Chantelle, Faull, Richard L. M., Dragunow, Mike, Curtis, Maurice A. · 2017 · Scientific Reports
Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
Veronica Ghiglieri, Valeria Calabrese, Paolo Calabresi · 2018 · Frontiers in Neurology
Postmortem interval effect on RNA and gene expression in human brain tissue
Alex C. Birdsill, Douglas G. Walker, Lih‐Fen Lue, Lucia I. Sue, Thomas G. Beach · 2010 · Cell and Tissue Banking
Adult neurogenesis in Parkinson’s disease
Franz Marxreiter, Martin Regensburger, Jürgen Winkler · 2012 · Cellular and Molecular Life Sciences
Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain
Koichi Wakabayashi, Fumiaki Mori, Kunikazu Tanji, Satoshi Orimo, Hitoshi Takahashi · 2010 · Acta Neuropathologica
A deadly spread: cellular mechanisms of α-synuclein transfer
Jennifer A. Steiner, Élodie Angot, Patrik Brundin · 2011 · Cell Death and Differentiation
Long-Term Health of Dopaminergic Neuron Transplants in Parkinson's Disease Patients
Penelope J. Hallett, Oliver Cooper, Damaso Sadi, H.A. Robertson, Ivar M. Mendez, Ole Isacson A · 2014 · Cell Reports
Gut dysfunction in Parkinson's disease
Adreesh Mukherjee, Atanu Biswas, Shyamal Kumar Das · 2016 · World Journal of Gastroenterology
The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
Couch, Yvonne, Alvarez-Erviti, Lydia, Sibson, Nicola R, Wood, Matthew JA, Anthony, Daniel C · 2011 · Journal of Neuroinflammation
Propagation of α-Synuclein Strains within Human Reconstructed Neuronal Network
Simona Gribaudo, Philippe Tixador, Luc Bousset, Alexis Fenyi, Patricia Lino, Ronald Melki, Jean‐Michel Peyrin, Anselme L. Perrier · 2019 · Stem Cell Reports
The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration
Maddalena Costanzo, Chiara Zurzolo · 2013 · Biochemical Journal
Loss of MicroRNA-7 Regulation Leads to α-Synuclein Accumulation and Dopaminergic Neuronal Loss In Vivo
Kirsty J. McMillan, Tracey K. Murray, Nora Bengoa‐Vergniory, Oscar Cordero Llana, Jane Cooper, Amy M. Buckley, Richard Wade‐Martins, James B. Uney, Michael J. O’Neill, Liang Fong Wong et al. · 2017 · Molecular Therapy
Protective Effects of Neurotrophic Factor–Secreting Cells in a 6-OHDA Rat Model of Parkinson Disease
Ofer Sadan, Merav Bahat-Stromza, Yael Barhum, Yossef S. Levy, Anat Pisnevsky, Hagit Peretz, Avihay Bar Ilan, Shlomo Bulvik, Noam Shemesh, Dana Krepel et al. · 2009 · Stem Cells and Development
New Insights into Toxicity and Drug Testing
Sivakumar JT Gowder · 2013 · InTech eBooks
Oxidative and nitrative alpha‐synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies
Schildknecht, Stefan, Gerding, Hanne R., Karreman, Christiaan, Drescher, Malte, Lashuel, Hilal A., Outeiro, Tiago F., Di Monte, Donato A., Leist, Marcel · 2013 · Journal of Neurochemistry
Disentangling the Relationship between Lewy Bodies and Nigral Neuronal Loss in Parkinson's Disease
Laura Parkkinen, Sean S. O’Sullivan, Catherine Collins, Aviva Petrie, Janice L. Holton, Tamás Révész, Andrew John Lees · 2011 · Journal of Parkinson s Disease
Treatments for Parkinson disease—past achievements and current clinical needs
Werner H Poewe · 2009 · Neurology
Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
Miquel Vila · 2019 · Movement Disorders
Invited Review: The role of prion‐like mechanisms in neurodegenerative diseases
Zane Jaunmuktane, Sebastian Brandner · 2019 · Neuropathology and Applied Neurobiology
The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease
Alyce C. Russell, Mirna Šimurina, Monique Garcia, Mislav Novokmet, Youxin Wang, Igor Rudan, Harry J. Campbell, Gordan Lauc, Meghan G. Thomas, Wei Wang · 2017 · Glycobiology
The prion hypothesis: from biological anomaly to basic regulatory mechanism
Tuite, Mick F., Serio, Tricia R. · 2010 · Nature Reviews Molecular Cell Biology
Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases
Ronald Melki · 2015 · Journal of Parkinson s Disease
Diet in Parkinson’s Disease: Critical Role for the Microbiome
Jackson, Aeja, Forsyth, Christopher B., Shaikh, Maliha, Voigt, Robin M., Engen, Phillip A., Ramirez, Vivian, Keshavarzian, Ali · 2019 · Frontiers in Neurology
Prion-like Mechanisms in the Pathogenesis of Tauopathies and Synucleinopathies
Michel Goedert, Ben Falcon, Florence Clavaguera, Markus Tolnay · 2014 · Current Neurology and Neuroscience Reports
Awareness and current knowledge of Parkinson’s disease: a neurodegenerative disorder
Asmat Ullah Khan, Muhammad Akram, Muhammad Daniyal, Rida Zainab · 2018 · International Journal of Neuroscience
Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration
Christopher M. Henstridge, Makis Tzioras, Rosa Chiara Paolicelli · 2019 · Frontiers in Cellular Neuroscience
The Gut and Parkinson's Disease—A Bidirectional Pathway
Susanne Fonseca Santos, Hadassa Loth de Oliveira, Elizabeth Sumi Yamada, Bianca Cruz Neves, Antônio Pereira · 2019 · Frontiers in Neurology
Exosomes in Parkinson disease
Jennifer R. Pinnell, Mei Cui, Kim Tieu · 2020 · Journal of Neurochemistry
Mechanisms of protein toxicity in neurodegenerative diseases
Chung, Chang Geon, Lee, Hyosang, Lee, Sung Bae · 2018 · Cellular and Molecular Life Sciences
Pluripotent stem cell-based therapy for Parkinson’s disease: Current status and future prospects
Kai‐Christian Sonntag, Bin Song, Nayeon Lee, Jin Hyuk Jung, Young Cha, Pierre R Leblanc, Carolyn Neff, Sek Won Kong, Bob S. Carter, Jeffrey Schweitzer et al. · 2018 · Progress in Neurobiology
Brain Injection of α-Synuclein Induces Multiple Proteinopathies, Gliosis, and a Neuronal Injury Marker
Sacino, Amanda N., Brooks, Mieu, McKinney, Alex B., Thomas, Michael A., Shaw, Gerry, Golde, Todd E., Giasson, Benoit I. · 2014 · The Journal of Neuroscience
Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?
Thomas A. Bayer · 2013 · European Neuropsychopharmacology
Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
Caiyun Liu, Xu Wang, Chang Liu, Hongliang Zhang · 2019 · Frontiers in Cellular Neuroscience
Cell-to-Cell Transmission of Tau and α-Synuclein
Norihito Uemura, Maiko T. Uemura, Kelvin C. Luk, Virginia M.‐Y. Lee, John Q. Trojanowski · 2020 · Trends in Molecular Medicine
Therapeutic prospects for Parkinson disease
C. Warren Olanow, Anthony H.V. Schapira · 2013 · Annals of Neurology
Neural grafting in Parkinson’s disease
Patrik Brundin, Roger A. Barker, Malin Parmar · 2010 · Progress in brain research
Stem cells: a promising candidate to treat neurological disorders
Min Zheng, Hua Han, Changgeng Song, Yizhe Zhang, Hai-Ning Wu, Xiu‐Li Cao, Chenjun Guo, Yongqiang Li · 2018 · Neural Regeneration Research
Emerging restorative treatments for Parkinson's disease
Tomas Deierborg, Denis Soulet, Laurent Roybon, Vanessa Jane Hall, Patrik Brundin · 2008 · Progress in Neurobiology
The Origins of Oxidant Stress in Parkinson's Disease and Therapeutic Strategies
Dalton James Surmeier, Jaime N. Guzmán, Javier Sánchez-Padilla, Joshua A. Goldberg · 2010 · Antioxidants and Redox Signaling
Animal Models of Parkinson’s Disease
Elena A. Konnova, Maria Swanberg · 2018 · Codon Publications eBooks
Membrane Interaction of α-Synuclein in Different Aggregation States
Marie Grey, Sara Snogerup Linse, Hanna Nilsson, Patrik Brundin, Emma Sparr · 2011 · Journal of Parkinson s Disease
Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type
Elisabet Ihse, Hodaka Yamakado, Xander M. van Wijk, Roger Lawrence, Jeffrey D. Esko, Eliezer Masliah · 2017 · Scientific Reports
Nanozyme scavenging ROS for prevention of pathologic α-synuclein transmission in Parkinson’s disease
Yuqing Liu, Yuanyang Mao, Enquan Xu, Huimin Jia, Shu Zhang, Valina Lynn Dawson, Ted M. Dawson, Yanmei Li, Zhi Guo Zheng, Weiwei He et al. · 2020 · Nano Today
Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
Brás, Inês C., Outeiro, Tiago F. · 2021 · Cells
The AAA-ATPase VPS4 Regulates Extracellular Secretion and Lysosomal Targeting of α-Synuclein
Takafumi Hasegawa, Masatoshi Konno, Toru Baba, Naoto Sugeno, Akio Kikuchi, Michiko Kobayashi, Emiko Miura, Nobuyuki Tanaka, Keiichi Tamai, Katsutoshi Furukawa et al. · 2011 · PLoS ONE
Amyloid Fibril Polymorphism Is under Kinetic Control
Riccardo Pellarin, Philipp Schüetz, Enrico Guarnera, Amedeo Caflisch · 2010 · Journal of the American Chemical Society
Tau strains shape disease
Jaime Vaquer‐Alicea, Marc I. Diamond, Łukasz A. Joachimiak · 2021 · Acta Neuropathologica
E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment
Kristel L. Emmer, Elisa A. Waxman, Jason P. Covy, Benoit I. Giasson · 2011 · Journal of Biological Chemistry
Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson’s Disease
Diana Alarcón-Arís, Ariadna Recasens, Mireia Galofré, Iria Carballo‐Carbajal, Nicolás Zacchi, Esther Ruiz‐Bronchal, Rubén Pavia-Collado, Rosario Chica, Albert Ferrés‐Coy, Marina Santos et al. · 2017 · Molecular Therapy